OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the ...

The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...

FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...

SIOUX FALLS, SD - January 23, 2026 - PRESSADVANTAGE - Vance Thompson Vision is drawing attention to its advanced ...

LONDON and NEW YORK, Jan. 23, 2026), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseas ...

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Fund” fourth-quarter 2025 ...

Leaving mascara on while sleeping may seem harmless, but it can lead to long-term irritation and even corneal damage ...

What makes glaucoma especially dangerous is its lack of early symptoms. A doctor explains why screening matters.

If you were to listen to a day in the life of a veterinary ophthalmologist, you’d likely hear words and phrases you’ve never heard before. “A tubing system will be placed under your horse’s eyelid to ...

OMAHA, NE - January 21, 2026 - PRESSADVANTAGE - Kugler Vision has released a new educational article titled "SMILE vs ...

The Lions Journey for Sight, which sees snowmobilers riding sleds from Flin Flon to southern Manitoba communities each winter ...